Inhaled Corticosteroids and COVID-19: a Systematic Review and Clinical Perspective

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2020 Apr 29

PMID 32341100

Citations 153

Authors

David M G Halpin

Dave Singh

Ruth M Hadfield

Affiliations

Soon will be listed here.

Citing Articles

Using Quantitative Bias Analysis to Adjust for Misclassification of COVID-19 Outcomes: An Applied Example of Inhaled Corticosteroids and COVID-19 Outcomes.

Bokern M, Rentsch C, Quint J, Hunnicutt J, Douglas I, Schultze A Pharmacoepidemiol Drug Saf. 2025; 34(1):e70086.

PMID: 39776023 PMC: 11706700. DOI: 10.1002/pds.70086.

Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workers.

Eiken A, Bliddal S, Villumsen M, Iversen K, Bundgaard H, Hasselbach R PLoS One. 2024; 19(11):e0311260.

PMID: 39602471 PMC: 11602038. DOI: 10.1371/journal.pone.0311260.

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.

Mia M, Howlader M, Akter F, Hossain M Clin Pathol. 2024; 17:2632010X241263054.

PMID: 39070952 PMC: 11282570. DOI: 10.1177/2632010X241263054.

Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.

Elneima O, Hurst J, Echevarria C, Quint J, Walker S, Siddiqui S ERJ Open Res. 2024; 10(4).

PMID: 39010888 PMC: 11247371. DOI: 10.1183/23120541.00982-2023.

Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study.

Pina Belmonte A, Madrazo M, Piles L, Rubio-Rivas M, de Jorge Huerta L, Gomez Antunez M Can J Respir Ther. 2024; 60:86-94.

PMID: 38855380 PMC: 11161176. DOI: 10.29390/001c.118514.

References

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Jeon S, Ko M, Lee J, Choi I, Byun S, Park S . Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrob Agents Chemother. 2020; 64(7). PMC: 7318052. DOI: 10.1128/AAC.00819-20. View

Bochkov Y, Busse W, Brockman-Schneider R, Evans M, Jarjour N, McCrae C . Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses. Respir Res. 2013; 14:98. PMC: 3851834. DOI: 10.1186/1465-9921-14-98. View

Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K . Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020; 58(3):155-168. PMC: 7102607. DOI: 10.1016/j.resinv.2019.12.005. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Stockman L, Bellamy R, Garner P . SARS: systematic review of treatment effects. PLoS Med. 2006; 3(9):e343. PMC: 1564166. DOI: 10.1371/journal.pmed.0030343. View

Simpson J, Carroll M, Yang I, Reynolds P, Hodge S, James A . Reduced Antiviral Interferon Production in Poorly Controlled Asthma Is Associated With Neutrophilic Inflammation and High-Dose Inhaled Corticosteroids. Chest. 2016; 149(3):704-13. DOI: 10.1016/j.chest.2015.12.018. View

Lewis T, Henderson T, Carpenter A, Ramirez I, McHenry C, Goldsmith A . Nasal cytokine responses to natural colds in asthmatic children. Clin Exp Allergy. 2012; 42(12):1734-44. PMC: 4219353. DOI: 10.1111/cea.12005. View

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team . The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Wkly. 2021; 2(8):113-122. PMC: 8392929. View

10.

Oliver B, Robinson P, Peters M, Black J . Viral infections and asthma: an inflammatory interface?. Eur Respir J. 2014; 44(6):1666-81. DOI: 10.1183/09031936.00047714. View

11.

Contoli M, Pauletti A, Rossi M, Spanevello A, Casolari P, Marcellini A . Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. Eur Respir J. 2017; 50(4). DOI: 10.1183/13993003.00451-2017. View

12.

Davies J, Carroll M, Li H, Poh A, Kirkegard D, Towers M . Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One. 2011; 6(11):e27898. PMC: 3220700. DOI: 10.1371/journal.pone.0027898. View

13.

Johnston S . Overview of virus-induced airway disease. Proc Am Thorac Soc. 2005; 2(2):150-6. DOI: 10.1513/pats.200502-018AW. View

14.

Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W . The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020; 95(1). PMC: 7737752. DOI: 10.1128/JVI.01648-20. View

15.

Yang I, Clarke M, Sim E, Fong K . Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012; (7):CD002991. PMC: 8992433. DOI: 10.1002/14651858.CD002991.pub3. View

16.

Southworth T, Pattwell C, Khan N, Mowbray S, Strieter R, Erpenbeck V . Increased type 2 inflammation post rhinovirus infection in patients with moderate asthma. Cytokine. 2019; 125:154857. DOI: 10.1016/j.cyto.2019.154857. View

17.

Yang M, Chen H, Zhang Y, Du Y, Xu Y, Jiang P . Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis. Inhal Toxicol. 2017; 29(5):219-226. DOI: 10.1080/08958378.2017.1346006. View

18.

Halpin D, Faner R, Sibila O, Badia J, Agusti A . Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?. Lancet Respir Med. 2020; 8(5):436-438. PMC: 7270536. DOI: 10.1016/S2213-2600(20)30167-3. View

19.

Wark P, Grissell T, Davies B, See H, Gibson P . Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains. Respirology. 2009; 14(2):180-6. DOI: 10.1111/j.1440-1843.2009.01480.x. View

20.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View